A clinical study of MK-4646 in people with HIV (MK-4646-003)
MK-4646-003
Phase 1 other active
Quick answer
A clinical study of MK-4646 in people with HIV (MK-4646-003) for HIV infection is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- HIV infection
- Phase
- Phase 1
- Modality
- other
- Status
- active